# Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia

> **NCT06957808** · NA · RECRUITING · sponsor: **King's College London** · enrollment: 30 (estimated)

## Conditions studied

- Schizophrenia Disorders

## Interventions

- **DRUG:** Diroximel fumarate (DRF)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06957808
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-10
- **Primary completion:** 2027-01-20
- **Final completion:** 2027-01-20
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06957808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06957808, "Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06957808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*